Supportively, CHR has also been reported to suppress MDR transporters (Brechbuhl et al., 2012) and to inhibit NF-κB signaling in various cancer models (Wu et al., 2018; Yeo et al., 2020). This evidence concerns the gene NFKB1 and cancer.